Mariner Wealth Advisors »

Contineum Therapeutics shares owned by Mariner Wealth Advisors

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Mariner Wealth Advisors from 13F filings

Historical chart of Mariner Wealth Advisors investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Mariner Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Mariner Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $122k 10k 11.75

More positions owned by Mariner Wealth Advisors

Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Broadcom (AVGO)
Amazon (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Mariner Wealth Advisors

Top funds holding Contineum Therapeutics

RA Capital Management
Johnson & Johnson
Suvretta Capital Management
Franklin Resources
Vanguard Group
Balyasny Asset Management
FMR
Sectoral Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management
Samsara BioCapital
Versant Venture Management
Point72 Asset Management

View all funds holding Contineum Therapeutics